author-photo

Michael C. Sheppard

University of Birmingham
Queen Elizabeth Hospital Birmingham

261

Papers

12537

Citations

Citation Trend

Filter By

Papers (189) Sort By

Journal Conference Others

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

2016 BMC Endocrine Disorders
Show All
- Source
- Cite
- Save
Citations (42)
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

2015 Pituitary
Show All
- Source
- Cite
- Save
Citations (51)
A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk

2014 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (25)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

2014 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (246)
Switching patients with acromegaly from octreotide LAR to pasireotide LAR improves biochemical control: crossover extension to a randomized, double-blind, multicenter, Phase III study

2013
Show All
- Source
- Cite
- Save
Citations (7)
Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study

2012
Show All
- Source
- Cite
- Save
Citations (3)
LADIES KENNEL ASSOCIATION OF NSW ALL BREEDS CHAMPIONSHIP SHOW

2012
Show All
- Source
- Cite
- Save
Citations (0)
Clinical, quality of life, and economic value of acromegaly disease control

2011 Pituitary
Show All
- Source
- Cite
- Save
Citations (124)
Management of acromegaly in Latin America: expert panel recommendations

2010 Pituitary
Show All
- Source
- Cite
- Save
Citations (35)
Il deficit di ACTH, le dosi più alte di terapia sostitutiva con idrocortisone e la radioterapia sono fattori predittivi indipendenti di mortalità nei pazienti con acromegalia

2010
Show All
- Source
- Cite
- Save
Citations (0)